On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A team consisting of leading virologists, microbiologists, high containment lab experts and animal modeling researchers are proposing several research projects to 1) establish a nonhuman primate model to study the pathogenesis and transmission as well as develop countermeasures; 2) test detection methods, including a project involving optofluidic chips, which screens specimens for the virus and determine stage; and 3) partner with other local and national scientists and clinicians on projects to identify potential therapies and vaccines for the virus.